Burson-Marsteller picks up Ferring Pharmaceuticals global comms account

Switzerland-based Ferring Pharmaceuticals has appointed Burson-Marsteller to provide global comms support across its key therapy brands following a pitch.

BM will work across the company's reproductive health, urology and gastroenterology therapy treatments, managing comms at a global, regional and national level.

The team will be led by Kate Hawker, managing director and chair of BM's healthcare practice, who said: "They [Ferring] are a company with numerous innovative, first-in-class products in their pipeline that will address current unmet needs in multiple patient populations. We look forward to helping Ferring bring these benefits to as many people as possible around the world."

Patrick Gorman, associate director, corporate comms at Ferring, added: "These are exciting times at Ferring with numerous product launches expected over the next couple of years. We wanted an agency to help us ensure that communications to our many stakeholders around the world are consistent, accurate and compelling. BM stood out in the pitches as having the expertise we need at both the global and the local levels."


Would you like to post a comment?

Please Sign in or register.